Estonia vs United Kingdom: Survival to age 65, female
Estonia
91.5%
in 2024
United Kingdom
91.6%
in 2024
Estonia rank
50th
United Kingdom rank
49th
Survival to age 65, female over time
- Estonia
- United Kingdom
How they compare
United Kingdom currently reports 91.6% against 91.5% in Estonia, a difference of 0.1%.
The two have swapped places 8 times across 65 shared years of data; in 1960 it was United Kingdom ahead.
Estonia ranks 50th and United Kingdom ranks 49th of 218 countries.
Across the 7 decades both report, Estonia averaged higher in 1 and United Kingdom in 6.
Head to head by decade
| Decade | Estonia | United Kingdom | Difference | Ahead |
|---|---|---|---|---|
| 1960s | 81.7% | 81.4% | 0.3% | Estonia |
| 1970s | 82.2% | 82.6% | 0.4% | United Kingdom |
| 1980s | 81.7% | 84.9% | 3.2% | United Kingdom |
| 1990s | 80.8% | 87.7% | 6.9% | United Kingdom |
| 2000s | 84.9% | 89.7% | 4.8% | United Kingdom |
| 2010s | 89.9% | 91.2% | 1.3% | United Kingdom |
| 2020s | 90.9% | 91.0% | 0.1% | United Kingdom |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher survival to age 65, female, Estonia or United Kingdom?
- United Kingdom, at 91.6% against 91.5% in Estonia as of 2024.
- What is the difference in survival to age 65, female between Estonia and United Kingdom?
- 0.1%, with United Kingdom ahead.
- How many years of comparable data are there for Estonia and United Kingdom?
- 65 years are reported by both, from 1960 to 2024.
- How do Estonia and United Kingdom rank globally for survival to age 65, female?
- Estonia ranks 50th and United Kingdom ranks 49th of 218 countries.
- Where does this data come from?
- World Population Prospects, United Nations (UN), publisher: UN Population Division, published as Survival to age 65, female (% of cohort). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Survival to age 65 refers to the percentage of a cohort of newborn infants that would survive to age 65, if subject to age specific mortality rates of the specified year.